Acquired by Pfizer in Dec 2023
SGEN - Seagen Inc.
NASDAQ
->
Healthcare
->
Biotechnology
Bothell,
United States
Type: Equity
SGEN price evolution
SGEN
| (in millions $) | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 | 31 Jan 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $428.57 | $308.44 | $335.85 | $319.94 |
| Short term investments | $808.42 | $983.68 | $1154.42 | $1415.13 |
| Net receivables | $631.55 | $586.05 | $495.78 | $501.91 |
| Inventory | $531.19 | $486.85 | $477.69 | $427.21 |
| Total current assets | $2551.59 | $2515.7 | $2601.91 | $2802.53 |
| Long term investments | ||||
| Property, plant & equipment | $487.66 | $428.15 | $378.96 | $294.92 |
| Goodwill & intangible assets | $494.93 | $500.74 | $506.5 | $512.19 |
| Total noncurrent assets | $1082.67 | $979.69 | $941.38 | $872 |
| Total investments | $808.42 | $983.68 | $1154.42 | $1415.13 |
| Total assets | $3634.26 | $3495.38 | $3543.3 | $3674.53 |
| Current liabilities | ||||
| Accounts payable | $224.81 | $114.42 | $141.47 | $207.85 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $954.72 | $762.9 | $713.23 | $818.4 |
| Long term debt | $113.49 | $97.24 | $91.13 | $43.47 |
| Total noncurrent liabilities | $129.12 | $113.42 | $106.91 | $52.31 |
| Total debt | $113.49 | $97.24 | $91.13 | $43.47 |
| Total liabilities | $1083.84 | $876.32 | $820.14 | $870.71 |
| Shareholders' equity | ||||
| Retained earnings | -$2756.4 | -$2540.61 | -$2329.08 | -$2154.35 |
| Other shareholder equity | $4.39 | $4.11 | $3.71 | $3.51 |
| Total shareholder equity | $2550.42 | $2619.06 | $2723.16 | $2803.82 |
| (in millions $) | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $319.94 | $424.83 | $558.42 | $274.56 |
| Short term investments | $1415.13 | $1735.2 | $2001 | $536.49 |
| Net receivables | $501.91 | $389.26 | $324.99 | $236 |
| Inventory | $427.21 | $200.66 | $116.14 | $85.93 |
| Total current assets | $2802.53 | $2869.19 | $3062.38 | $1176.64 |
| Long term investments | $100.83 | $57.28 | ||
| Property, plant & equipment | $294.92 | $267.96 | $258.18 | $220.72 |
| Goodwill & intangible assets | $512.19 | $535.26 | $558.35 | $274.67 |
| Total noncurrent assets | $872 | $850.41 | $938.52 | $1029.22 |
| Total investments | $1415.13 | $1735.2 | $2101.83 | $593.78 |
| Total assets | $3674.53 | $3719.6 | $4000.91 | $2205.87 |
| Current liabilities | ||||
| Accounts payable | $207.85 | $114.82 | $78.07 | $52.29 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $818.4 | $568.85 | $388.14 | $259.36 |
| Long term debt | $43.47 | $56.66 | $61.88 | $67.61 |
| Total noncurrent liabilities | $52.31 | $85.61 | $124.67 | $70.22 |
| Total debt | $43.47 | $56.66 | $61.88 | $67.61 |
| Total liabilities | $870.71 | $654.47 | $512.81 | $329.58 |
| Shareholders' equity | ||||
| Retained earnings | -$2154.35 | -$1544.04 | -$869.57 | -$1483.24 |
| Other shareholder equity | $3.51 | $1.18 | $0.56 | $0.23 |
| Total shareholder equity | $2803.82 | $3065.14 | $3488.1 | $1876.29 |
| (in millions $) | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 | 31 Dec 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $648.65 | $603.83 | $519.72 | $528.15 |
| Cost of revenue | $165.25 | $180.75 | $111.78 | $108.21 |
| Gross Profit | $483.4 | $423.08 | $407.94 | $419.94 |
| Operating activities | ||||
| Research & development | $449.05 | $399.87 | $356.01 | $357.84 |
| Selling, general & administrative | $265.69 | $243.93 | $236.44 | $216.1 |
| Total operating expenses | $714.73 | $643.8 | $592.46 | $573.94 |
| Operating income | -$231.34 | -$220.72 | -$184.51 | -$154 |
| Income from continuing operations | ||||
| EBIT | -$216.36 | -$208.64 | -$170.11 | -$143.83 |
| Income tax expense | -$0.57 | $2.89 | $4.62 | $4.34 |
| Interest expense | ||||
| Net income | ||||
| Net income | -$215.79 | -$211.53 | -$174.74 | -$148.17 |
| Income (for common shares) | -$215.79 | -$211.53 | -$174.74 | -$148.17 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1962.41 | $1574.37 | $2175.54 | $916.71 |
| Cost of revenue | $410.06 | $311.56 | $217.72 | $43.95 |
| Gross Profit | $1552.35 | $1262.81 | $1957.82 | $872.76 |
| Operating activities | ||||
| Research & development | $1344.36 | $1228.67 | $827.13 | $719.37 |
| Selling, general & administrative | $820.96 | $716.19 | $533.84 | $373.93 |
| Total operating expenses | $2165.32 | $1944.86 | $1360.96 | $1093.31 |
| Operating income | -$612.97 | -$682.06 | $596.85 | -$220.54 |
| Income from continuing operations | ||||
| EBIT | -$602.32 | -$675.71 | $615.7 | -$158.65 |
| Income tax expense | $7.99 | -$1.23 | $2.03 | |
| Interest expense | ||||
| Net income | ||||
| Net income | -$610.31 | -$674.47 | $613.67 | -$158.65 |
| Income (for common shares) | -$610.31 | -$674.47 | $613.67 | -$158.65 |
| (in millions $) | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 | 31 Dec 2022 |
|---|---|---|---|---|
| Net income | -$215.79 | -$211.53 | -$174.74 | -$148.17 |
| Operating activities | ||||
| Depreciation | $22.99 | $21.57 | $22.09 | $20.81 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $131.34 | $93.22 | $63.94 | $64.32 |
| Total cash flows from operations | -$35.82 | -$175.25 | -$249.64 | -$79.44 |
| Investing activities | ||||
| Capital expenditures | -$43.93 | -$49.23 | -$38.66 | -$29.25 |
| Investments | $186.65 | $182.69 | $273.35 | -$5.02 |
| Total cash flows from investing | $142.49 | $133.09 | $232.34 | -$36.49 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $15.52 | $13.81 | $42.24 | $65.35 |
| Net borrowings | ||||
| Total cash flows from financing | $15.52 | $13.81 | $29.94 | $65.35 |
| Effect of exchange rate | -$2.29 | $0.57 | $0.92 | $5.7 |
| Change in cash and equivalents | $119.9 | -$27.78 | $13.55 | -$44.88 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Net income | -$610.31 | -$674.47 | $613.67 | -$158.65 |
| Operating activities | ||||
| Depreciation | $82.16 | $78.63 | $63.38 | $33.51 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $221.3 | $173.12 | $147.23 | $127.35 |
| Total cash flows from operations | -$453.75 | -$499.01 | $856.57 | -$163.74 |
| Investing activities | ||||
| Capital expenditures | -$77.34 | -$52.33 | -$82.41 | -$70.75 |
| Investments | $325.74 | $341.21 | -$1336.6 | -$206.98 |
| Total cash flows from investing | $228.24 | $288.88 | -$1419.01 | -$277.73 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $125.36 | $77.78 | $846.11 | $637.84 |
| Net borrowings | ||||
| Total cash flows from financing | $125.36 | $77.78 | $846.11 | $637.84 |
| Effect of exchange rate | -$1.19 | -$1.25 | $0.2 | |
| Change in cash and equivalents | -$101.35 | -$133.59 | $283.86 | $196.38 |
News
Fundamentals
| Market cap | $43.15B |
|---|---|
| Enterprise value | $42.83B |
| Shares outstanding | 188.63M |
| Revenue | $2.30B |
|---|---|
| EBITDA | -$651.47M |
| EBIT | -$738.94M |
| Net Income | -$750.23M |
| Revenue Q/Q | 27.11% |
| Revenue Y/Y | 23.40% |
| P/E ratio | -57.51 |
|---|---|
| EV/Sales | 18.62 |
| EV/EBITDA | -65.75 |
| EV/EBIT | -57.96 |
| P/S ratio | 18.76 |
| P/B ratio | 16.95 |
| Book/Share | 13.50 |
| Cash/Share | 2.27 |
| EPS | -$3.98 |
|---|---|
| ROA | -20.92% |
| ROE | -28.06% |
| Debt/Equity | 0.31 |
|---|---|
| Net debt/EBITDA | -1.01 |
| Current ratio | 2.67 |
| Quick ratio | 2.12 |